Last update 08 May 2025

APP x FBXO3

Basic Info

Related Targets
APPFBXO3

Related

1
Drugs associated with APP x FBXO3
Ginsenoside Rg1
Target
APP x FBXO3
Mechanism
APP inhibitors [+1]
Active Org.
Kunming Medical UniversityKunming Medical University [+2]
Originator Org.-
Active Indication
postoperative cognitive dysfunction [+1]
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
1
Clinical Trials associated with APP x FBXO3
ChiCTR2200055194
/ RecruitingEarly Phase 1IIT
A randomized controlled clinical trial of ginsenoside Rg1 combined with reduced glutathione in the treatment of diabetic wounds
100 Clinical Results associated with APP x FBXO3
Login to view more data
100 Translational Medicine associated with APP x FBXO3
Login to view more data
0 Patents (Medical) associated with APP x FBXO3
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free